Clinical characteristics of pulmonary hypertension in patients with pleuroparenchymal fibroelastosis.

Abstract

This study aimed to investigate the clinical characteristics and prognosis of patients with pleuroparenchymal fibroelastosis (PPFE) and pulmonary hypertension (PH). We retrospectively analyzed the data of patients who were diagnosed with PPFE and underwent transthoracic echocardiography (TTE) for the evaluation of their right heart systems within 3 months of their first visit between 2011 and 2018. Patients were divided into the PH and non-PH groups based on their peak tricuspid regurgitation velocity (TRV) on TTE (cutoff, 2.8m/s). The clinical characteristics of PH and association between PH and survival among patients with PPFE were investigated. In total, 83 patients were enrolled. Sixteen (19.3%) patients were included in the PH group. The PH group had a lower body mass index, percent predicted forced vital capacity (FVC), 6-min walk distance, and partial pressure of arterial oxygen than the non-PH group. There was no significant difference in the presence of usual interstitial pneumonia patterns in the lower lobes between the two groups. The survival period was significantly shorter in the PH group than in the non-PH group (median survival 16.3 versus 50.2 months, log-rank p<0.001). The multivariate Cox proportional hazard model showed that male sex (hazard ratio [HR]=4.83, p<0.001), Krebs von den Lungen-6 (KL-6) > 550 U/mL (HR=3.48, p=0.005), %FVC < 50% (HR=3.04, p=0.028), and peak TRV > 2.8m/s (HR=3.26, p=0.038) were independently associated with poor survival. PH was not rare in patients with PPFE. Male sex, increased KL-6, lower FVC, and PH were independently associated with poor survival in patients with PPFE.